Evidence map›Paper›PMID 28764768›Full record

ArticleInternational journal for equity in health2017

More than a virus: a qualitative study of the social implications of hepatitis B infection in China.

J Wallace, M Pitts, C Liu, V Lin, B Hajarizadeh, J Richmond, S Locarnini

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal for equity in health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07053449 (The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07053449 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical (Social) Harms Amongst Migrant Populations: A Qualitative Study. (B-SOCIAL)

TypeobservationalSponsorNottingham University Hospitals NHS TrustRan2025 to 2026Enrolled30ConditionsHepatitis B Virus (HBV)
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. An Intersectional Approach to Hepatitis B.International journal of environmental research and public health · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

J WallaceAustralian Research Centre in Sex, Health and Society, La Trobe University, 215 Franklin Street, Melbourne, Victoria, 3000, Australia. j.wallace@latrobe.edu.au.
M PittsAustralian Research Centre in Sex, Health and Society, La Trobe University, 215 Franklin Street, Melbourne, Victoria, 3000, Australia.
C LiuChina Health Program, La Trobe University, Melbourne, Australia.
V LinDepartment of Public Health, La Trobe University, Melbourne, Australia.
B HajarizadehAustralian Research Centre in Sex, Health and Society, La Trobe University, 215 Franklin Street, Melbourne, Victoria, 3000, Australia.
J RichmondAustralian Research Centre in Sex, Health and Society, La Trobe University, 215 Franklin Street, Melbourne, Victoria, 3000, Australia.
S LocarniniVictorian Infectious Diseases Reference Laboratory, Director, WHO Regional Reference Laboratory for Hepatitis B, Doherty Institute, Melbourne, Australia.
La Trobe University · AUVictorian Infectious Diseases Reference Laboratory · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChina has the largest absolute number of people living with hepatitis B with up to 300,000 people estimated to die each year from hepatitis B related diseases. Despite advances in immunisation, clinical management, and health policy, there is still a lack of accessible and affordable health care for people with hepatitis B. Through in-depth interviews, this study identifies the personal, social and economic impact of living with hepatitis B and considers the role of stigma and discrimination as barriers to effective clinical management of the disease.

methodsSemi-structured qualitative interviews were held with 41 people living with hepatitis B in five Chinese cities. Participants were recruited through clinical and non-government organisations providing services to people with hepatitis B, with most (n = 32) being under the age of 35 years.

resultsPeople living with hepatitis B experience the disease as a transformative intergenerational chronic infection with multiple personal and social impacts. These include education and employment choices, economic opportunities, and the development of intimate relationships. While regulations reducing access to employment and education for people with hepatitis B have been repealed, stigma and discrimination continue to marginalise people with hepatitis B.

conclusionsEffective public policy to reduce morbidity and mortality associated with hepatitis B needs to address the lived impact of hepatitis B on families, employment and educational choices, finances, and social marginalisation.

Indexed as

Social DiscriminationSocial StigmaAdultChinaFemaleHealth Services AccessibilityHepatitis BHumansMaleMiddle AgedQualitative ResearchSocioeconomic FactorsYoung AdultChinaHealth care accessHepatitis BQualitative studySocial impactStigma

Identifiers

PMID28764768
PMCPMC5540563
OpenAlexW2741828753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.